Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

12.02.2024

1 Am J Respir Crit Care Med
1 Ann Intern Med
2 Antiviral Res
5 BMJ
1 Clin Infect Dis
1 Eur J Radiol
1 Infect Control Hosp Epidemiol
2 Int J Infect Dis
1 J Infect
5 J Med Virol
1 J Virol
2 JAMA
2 Lancet Infect Dis
1 N Engl J Med
1 Radiol Cardiothorac Imaging
1 Science
2 Zhonghua Jie He He Hu Xi Za Zhi



    Am J Respir Crit Care Med

  1. GAURAV R
    SARS-CoV-2 Lurking and Lingering in the Depths of Lungs.
    Am J Respir Crit Care Med. 2024 Feb 7. doi: 10.1164/rccm.202401-0067.
    >> Share


    Ann Intern Med

  2. OLFSON M, McClellan C, Zuvekas SH, Wall M, et al
    Trends in Psychological Distress and Outpatient Mental Health Care of Adults During the COVID-19 Era.
    Ann Intern Med. 2024 Feb 6. doi: 10.7326/M23-2824.
    >> Share


    Antiviral Res

  3. SINHA D, Yaugel-Novoa M, Waeckel L, Paul S, et al
    Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses.
    Antiviral Res. 2024 Feb 6:105823. doi: 10.1016/j.antiviral.2024.105823.
    >> Share

  4. WANG Y, Liu Y, Wang J, Zhang M, et al
    An adenovirus-vectored vaccine based on the N protein of feline coronavirus elicit robust protective immune responses.
    Antiviral Res. 2024;223:105825.
    >> Share


    BMJ

  5. HINMAN RS, Maher CG
    Rehabilitation for post-covid-19 condition.
    BMJ. 2024;384:q20.
    >> Share

  6. MCGREGOR G, Sandhu H, Bruce J, Sheehan B, et al
    Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial.
    BMJ. 2024;384:e076506.
    >> Share

  7. FELDMAN JM, Bassett MT
    US public health after covid-19: learning from the failures of the hollow state and racial capitalism.
    BMJ. 2024;384:e076969.
    >> Share

  8. MORRISON JS, Gayle HD
    After covid-19: the case for optimism for US leadership in global health.
    BMJ. 2024;384:q138.
    >> Share

  9. WISE J
    Covid inquiry: Tears and tensions as Sturgeon takes the stand.
    BMJ. 2024;384:q289.
    >> Share


    Clin Infect Dis

  10. MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
    Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
    Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
    >> Share


    Eur J Radiol

  11. FOOLADI M, Soleymani Y, Rahmim A, Farzanefar S, et al
    Impact of different reconstruction algorithms and setting parameters on radiomics features of PSMA PET images: A preliminary study.
    Eur J Radiol. 2024;172:111349.
    >> Share


    Infect Control Hosp Epidemiol

  12. LINDER JA, Persell SD, Kelley MA, Friedberg M, et al
    Antibiotic prescribing for acute respiratory infections during the coronavirus disease 2019 (COVID-19) pandemic: Patterns in a nationwide telehealth service provider.
    Infect Control Hosp Epidemiol. 2024 Feb 8:1-4. doi: 10.1017/ice.2023.
    >> Share


    Int J Infect Dis

  13. FUENTE A, Postigo T, Ferri FS, Dominguez-Gil M, et al
    Synergistic impact of N-antigenemia profiled by a rapid antigen test and low anti-S1 antibodies on the risk of hospitalization in COVID-19.
    Int J Infect Dis. 2024 Feb 2:S1201-9712(24)00019.
    >> Share

  14. XIA Q, Yang Y, Wang F, Huang Z, et al
    Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents.
    Int J Infect Dis. 2024 Feb 1:S1201-9712(24)00018.
    >> Share


    J Infect

  15. HUNG KC, Chen IW, Sun CK
    Pulmonary dysfunction severity may impact optimal dexamethasone dosing in patients with COVID-19.
    J Infect. 2024 Feb 1:S0163-4453(24)00031-8. doi: 10.1016/j.jinf.2024.
    >> Share


    J Med Virol

  16. GAN M, Cao J, Zhang Y, Fu H, et al
    Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    J Med Virol. 2024;96:e29452.
    >> Share

  17. NEDELCU I, Florian P, Ion D, Militaru E, et al
    Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients.
    J Med Virol. 2024;96:e29448.
    >> Share

  18. PASSOS V, Henkel LM, Wang J, Zapatero-Belinchon FJ, et al
    Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.
    J Med Virol. 2024;96:e29455.
    >> Share

  19. CHANG LC, Chen IW, Hung KC
    Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19.
    J Med Virol. 2024;96:e29464.
    >> Share

  20. SELVAVINAYAGAM ST, Suvaithenamudhan S, Yong YK, Hemashree K, et al
    Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
    J Med Virol. 2024;96:e29456.
    >> Share


    J Virol

  21. VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
    J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
    >> Share


    JAMA

  22. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    >> Share

  23. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    >> Share


    Lancet Infect Dis

  24. ODA Y, Kumagai Y, Kanai M, Iwama Y, et al
    Persistence of immune responses of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2.
    Lancet Infect Dis. 2024 Feb 1:S1473-3099(24)00060.
    >> Share

  25. BERTRAN M, D'Aeth JC, Abdullahi F, Eletu S, et al
    Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study.
    Lancet Infect Dis. 2024 Feb 1:S1473-3099(23)00706.
    >> Share


    N Engl J Med

  26. BISSONNETTE R, Pinter A, Ferris LK, Gerdes S, et al
    An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis.
    N Engl J Med. 2024;390:510-521.
    >> Share


    Radiol Cardiothorac Imaging

  27. HONG YJ, Han K, Lee HJ, Hur J, et al
    Assessment of Feasibility and Interscan Variability of Short-time Cardiac MRI for Cardiotoxicity Evaluation in Breast Cancer.
    Radiol Cardiothorac Imaging. 2024;6:e220229.
    >> Share


    Science


  28. Erratum for the Research Article "Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain" by K. G. Nabel et al.
    Science. 2024;383:eado3845.
    >> Share


    Zhonghua Jie He He Hu Xi Za Zhi

  29. SHI YJ, Chen RX, Liu XN, Shao C, et al
    [Clinical analysis of COVID-19 in patients with preexisting interstitial lung abnormalities].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:126-131.
    >> Share

  30. ZHA SS, He ZF, Guan LL, Niu JY, et al
    [Clinical research progress in non-invasive positive pressure ventilation in 2023].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:146-151.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016